These findings raise the possibility of a shared germline–somatic axis in TGCT pathogenesis involving SPRY-mediated RAS/MAPK regulation, and point to a potential tumor-suppressive role for SPRY3 that warrants further investigation. This evidence concerns the gene SPRY3 and testicular germ cell tumor.